Volume : 09, Issue : 09, September – 2022
20.FORMULATION AND EVALUATION OF TRANSDERMAL PATCH LOADED WITH ONDANSETRON
* Armughan Aymen Mastan,* Syeda Juweria Qadri, Mr. M. Mushraff Ali Khan, K. Rama Rao
The purpose of this research was to develop and design a matrix-type transdermal therapeutic system that contains the drug Ondansetron along with different ratios of Xanthan Gum and Guar Gum forming hydrophilic polymer systems by film casting technique, using 15% v/w of Propylene Gylcol to the polymer weight, incorporated as plasticizer and DiMethyl Sulfoxide was used to enhance the transdermal permeation. These formulated transdermal patches were physically evaluated with regard to thickness, moisture content, moisture uptake, tensile strength, folding endurance, flatness and drug content. All prepared formulations indicated good physical stability. Ex-vivo permeation studies of formulations were performed by using Franz-Diffusion cells. It was observed that the formulation F8 shows better extended release when compared with other formulations and followed Higuchi model in dissolution study. The release rate found to follow Zero-Order rate kinetic. Primary irritation study shows that the prepared transdermal films are non-irritant. Transdermal delivery is a potential route for the administration of Ondansetron.
KEYWORDS: Ondansetron, Hydrophilic polymers, Transdermal Patch, Antiemetic.
Cite This Article:
Please cite this article in Armughan Aymen Mastan et al, Formulation and Evaluation Of Transdermal Patch loaded with ondansetron., Indo Am. J. P. Sci, 2022; 09(9).
Number of Downloads : 10
1. Ansel, Pharmaceutical Dosage form and Drug Delivery System, Lippincott, 7th edition: 553.
2. Gennaro R.A. Remington, The Science and Practice of Pharmacy., 20th ed. New York: Lippincott Williams: (2000) ,1045.
3. Chien Yie W., Transdermal Therapeutic systems, Controlled Drug Delivery: Fundamentals & Applications. Robinson Joseph R, Lee Vincent HL. Eds, New York: Marcel Dekker (1987), 523.
4. B.S. Dave et al., Studies on effect of Limonene and other formulation ingredients on permeation of Diclofenac sodium through rat skin, International Journal of Pharmaceutical Excipients, 2(2), (2003), 50-54.
5. Jitendra Banweer et al., Formulation, Optimization and Evaluation of Matrix type Transdermal system of Lisinopril Dihydrate Using Permeation Enhancers, Drug Invention Today, 2(2), (2010), 134-137.
6. A. Bhattacharya et al., Effect of hydrophobic permeation enhancers on the release and skin permeation kinetics from matrix type transdermal drug delivery system of ketotifen fumarate, Acta Poloniac Pharmaceutica-Drug Research, 58(2), (2001), 101-105.
7. Naohiro Nishida et al., Development and evaluation of a monolithic drug in adhesive patch for valsartan, International Journal of Pharmaceutics, 402, (2010), 103- 109.
8. Chien Yie W. Transdermal Therapeutic systems, Controlled Drug Delivery: Fundamentals & Applications. Robinson Joseph R, Lee Vincent HL. Eds, New York: Marcel Dekker (1987), 523.
9. Divyesh Patel et al., Transdermal drug delivery system: Review, International Journal of Biopharmaceutical and Toxicological Research, 1(1), (2011), 61-80.
10. N. S Chandrashekar et al., Physicochemical and Pharmacokinetic parameters in drug selection and loading for Transdermal drug delivery, Indian Journal of Pharmaceutical Sciences, (2008), 70.
11. Chien Yie W. In Transdermal Drug Delivery & Delivery Systems, Novel drug Delivery Systems. Eds, New York: Marcel Dekker (1992), 301.
12. S.P.Vyas and Khar, Control Drug Delivery Concepts and Advances, 411-447.
13. Snigdha Bharadwaj et al., Recent advancement in transdermal drug delivery system, International Journal of Pharma Professional’s Research, 2(1), (2011).
14. J. Ashok Kumar et al., Transdermal drug delivery system: An Overview, International Journal of Pharmaceutical Sciences Review and Research, 3(2), (2010), 49-54.
15. P. K. Gaurav et al., Transdermal drug delivery system: A Review, Asian Journal of Pharmaceutical and Clinical Research, 2(1), (2009), 14-20.
16. R. Panner Selvam et al., Transdermal drug delivery systems for antihypertensive drugs, International Journal of Pharmaceutical and Biomedical Research 01(01), (2010).
17. Jitendra Banweer et al., Formulation, Optimization and Evaluation of Matrix type Transdermal system of Lisinopril Dihydrate Using Permeation Enhancers, Drug Invention Today 2(2), (2010), 134-137.
18. Pravin Gavalis et al., Design and development of HPMC based polymeric film of enalapril, International Journal of Pharmatech Research, 2(1), (2010), 274-282.
19. Anampally S, Aukunuru J; Development of granisetron transdermal films: IN VITRO AND EX VIVO Characterization. Indian drugs May 2010. Page no. 21-28
20. J. R. D Gupta et al., Formulation and Evaluation of Matrix type Transdermal patches of glibenclamide., International Journal of Pharm sciences and Drug research.,2009.,1(1):46-50.
21. Mamatha T et al., Transdermal Drug Delivery System for Atomoxetine Hydrochloride – In vitro and Ex vivo Evaluation, Current Trends in Biotechnology and Pharmacy, Volume 3 (2) April – 2009.
22. Anil J Shinde et al., Development and characterization of transdermal therapeutics system of tramadol hydrochloride, Asian J Pharm 2008;2:265-9.
23. Ramesh Gannu et al., Development of Nitrendipine Transdermal Patches: In vitro and Ex vivo Characterization, Current Drug Delivery, 4, (2007), 69-76.
24. Gattani S.G et al., Formulation and evaluation of Transdermal films of Ondansetron Hydrochloride, Indian Drugs, 43(3), (2006), 245-250.
25. Sadhana P. Guptha et al., Effective and controlled transdermal delivery of Metoprolol Tartrate, Indian Journal of Pharmaceutical Sciences, 67(3), (2005) ,346-350.
26. M. Aqil et al., In vivo Characterization of Monolithic Matrix Type Transdermal Drug Delivery Systems of Pinacidil Monohydrate: A Technical Note, AAPS Pharm SciTech, (2005),1-10.
27. B.S. Dave et al., Studies on effect of Limonene and other formulation ingredients on permeation of Diclofenac sodium through rat skin, International Journal of Pharmaceutical Excipients, 2(2), (2003), 50-54.
28. Ramesh Panchagnula et al., Transdermal drug delivery of imipramine hydrochloride, Effect of terpenes, Journal of Controlled Release 79, (2002), 93â€ “101.
29. A. Bhattacharya et al., Effect of hydrophobic permeation enhancers on the release and skin permeation kinetics from matrix type transdermal drug delivery system of ketotifenfumerate, ActaPoloniacPharmaceutica-Drug Research 58(2), (2001), 101
30. Mandal S. C et al., In vitro release and permeation kinetics of pentazocine from matrix-dispersion type transdermal drug delivery systems, Drug Development and Industrial Pharmacy 20(11), (1994), 1933-1941.
31. Rao PR, Reddy MN. Comparative in-vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur J Pharm BioPharm 2003;56(1):81-5.
32. C. Amnuaikit and T. Kimura, Strategies for overcoming the stratum corneum: chemical and physical approaches, Am. J. Drug Deliv. 1 (2003) 187–214
33. Suchika Sharma., Design and evaluation of Olanzapine transdermal patches containing vegetable oils as permeation enhancers., Der Pharmacia Lettre, 2010, 2(6): 84-98.
34. Jayaprakash S, Sathish SK,Nagarajan M. Development and evaluation of risperidone membrane controlled transdermal therapeutic system. The Indian Pharmacist. 2007; July: 64‐66.
35. Sankar SR. Text book of pharmaceutical analysis. Rx Publications, Karnataka; 3rd End. 2001: 25(1) ‐25(5) Das M.K et al., Transdermal Delivery of Trazodone Hydrochloride from Acrylic Films Prepared from Aqueous Latex, Indian Journal Pharmaceutical Sciences, 68 (1), (2006) 1-32.
36. Panigrahi L et al., Permeation Kinetics of Diclofenac Sodium from Pseudo latex Transdermal Formulations through Lipidized and Delipidized Mouse skin, Indian Journal Pharmaceutical Sciences, 67(1), (2005), 124-127
37. Bronaugh RL. Determination of penetration absorption by in-vitro technique: percutaneous absorption. Brouangh RL. Maibach HI. editors. New York: Marcel Dekker, (1985) ,267-279.
38. Krishnaias YSR, Alsaidan MS, Chandrasekhar VD, Satyanarayana V. Bioavailability of nerodilol based transdermal therapeutic system of nicorandil in human volunteers. J. Controlled. Release. 2005 August; 106: 111‐122.
39. Prabhu Prabhakara, Marina Koland, Vijay Narayana K, Harish NM, Shankar G, Mohd
Gulzar Ahmed, Narayana Charyulu R, Satyanarayana D. 2010 “Preparation and evaluation of Transdermal patches of Papaverine hydrochloride”. Int. J. Res. Pharm, 1(3):259-266.
40. Wamorkar V.V, M Mohan Varma1, B. Vijaykumar. 2010 “Effect of Hydrophilic and Hydrophobic Polymers and in vitro Evaluation of Hydro Dynamically Balanced System of Metoclopramide Hydrochloride”. Int. J. Pharm Sci and Nanotechnology, 3(3): 1129-34.
41. S.Latha, P. Selvamani, C. Thirunavukkarasu R. Kadamba Vadani .2011 “Formulation Development and Comparison in Evaluation of Transdermal Drugs Delivery System for Anti-Emetic Therapy”. Int. J. Res. Pharm Biomed Sci, 2 (2): 525-28.
42. Saxena M, Mutalik S,Reddy M.s, 2006 “Formulation and Evaluation of Transdermal Patches of Metoclopramide Hydrochloride” Indian drugs, 43(9): 740-45.